Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Lefelsiran sodium by Novo Nordisk for Alcohol Dependence: Likelihood of Approval
Lefelsiran sodium is under clinical development by Novo Nordisk and currently in Phase I for Alcohol Dependence. According to GlobalData,...